Trends in Buprenorphine Coverage and Prior Authorization Requirements in US Commercial Formularies, 2017-2021
Ontology highlight
ABSTRACT: This cross-sectional study assesses buprenorphine coverage and prior authorization requirements in US commercial formulary data from 2017 to 2021.
SUBMITTER: Nguyen T
PROVIDER: S-EPMC9270692 | biostudies-literature |
REPOSITORIES: biostudies-literature
ACCESS DATA